Deliargyris Efthymios
SEC insider (Form 3/4/5 filer). CIK 0001751617. Chief Medical Officer at Cytosorbents Corp (CTSO). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 8, 2025. Located in PRINCETON, NJ.
Companies Deliargyris Efthymios has filed insider reports for
- Cytosorbents Corp (CTSO): Officer, Chief Medical Officer
Deliargyris Efthymios
CIK: 0001751617
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cytosorbents Corp
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 8, 2025CTSO
Cytosorbents Corp
AwardDirect70K shares- - Jan 17, 2025CTSO
Cytosorbents Corp
In-the-MoneyDirect16.2K shares at avg. $1.00$16K - Jan 17, 2025CTSO
Cytosorbents Corp
OtherDirectSeries A Right Warrants
16.2K shares- - Jan 17, 2025CTSO
Cytosorbents Corp
OtherDirectSeries B Right Warrants
16.2K shares- - Oct 4, 2024CTSO
Cytosorbents Corp
AwardDirectStock Option (Right to Buy)
100K shares- - Oct 4, 2024CTSO
Cytosorbents Corp
AwardDirectStock Option (Right to Buy)
50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 8, 2025 | CTSO Cytosorbents Corp | Award | 70,000 | - | - | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | In-the-Money | 16,233 | $1.00 | $16,233 | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | Other Series A Right Warrants | 16,233 | - | - | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | Other Series B Right Warrants | 16,233 | - | - | Direct |
| Oct 4, 2024 | CTSO Cytosorbents Corp | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| Oct 4, 2024 | CTSO Cytosorbents Corp | Award Stock Option (Right to Buy) | 50,000 | - | - | Direct |
1-6 of 6 transactions